Balance Sheet Gritstone bio, Inc.

Equities

GRTS

US39868T1051

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 11:27:48 2025-04-03 am EDT			5-day change	1st Jan Change
0.000001 ^USD	-90.00%		-.--%	-

25-04-04	Gritstone bio, Inc. Emerged from Bankruptcy	CI
25-04-03	First Amended Reorganization Plan Approved for Gritstone bio, Inc.	CI

b2bd3957c70f315656cb20a.Nqui2eRTaWEv1xVH-o5jumxDFmzR6FVwk5xaeuGL85U.UOWVsbEpMRBpgHJ2gMch7V45Zxyi0QFHotsFLK_fkuZiyNWcjDIFD0mHVA

Published financial data: GRITSTONE BIO, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	4.36M	3.46M	46.72M	9.27M	1.33M
Other Revenues, Total	-	575K	1.5M	10.68M	15.01M
Total Revenues	4.36M	4.04M	48.21M	19.94M	16.34M
Cost of Goods Sold, Total	82.9M	88.64M	97.49M	111M	127M
Gross Profit	-78.53M	-84.61M	-49.28M	-91.46M	-111M
Selling General & Admin Expenses, Total	19.41M	21.41M	25.93M	28.97M	28.78M
Other Operating Expenses, Total	19.41M	21.41M	25.93M	28.97M	28.78M
Operating Income	-97.94M	-106M	-75.21M	-120M	-140M
Interest Expense, Total	-	-	-	-1.24M	-4.04M
Interest And Investment Income	2.16M	581K	944K	1.98M	5.2M
Net Interest Expenses	2.16M	581K	944K	741K	1.16M
Other Non Operating Income (Expenses)	-	-	-	-	-32K
EBT, Excl. Unusual Items	-95.78M	-105M	-74.26M	-120M	-138M
Gain (Loss) On Sale Of Investments	1.35M	122K	-817K	-	-
EBT, Incl. Unusual Items	-94.43M	-105M	-75.08M	-120M	-138M
Earnings From Continuing Operations	-94.43M	-105M	-75.08M	-120M	-138M
Net Income to Company	-94.43M	-105M	-75.08M	-120M	-138M
Net Income - (IS)	-94.43M	-105M	-75.08M	-120M	-138M
Net Income to Common Incl Extra Items	-94.43M	-105M	-75.08M	-120M	-138M
Net Income to Common Excl. Extra Items	-94.43M	-105M	-75.08M	-120M	-138M
Per Share Items
Net EPS - Basic	-2.81	-2.79	-0.95	-1.32	-1.2
Basic EPS - Continuing Operations	-2.81	-2.79	-0.95	-1.32	-1.2
Basic Weighted Average Shares Outstanding	33.55M	37.79M	78.89M	90.92M	116M
Net EPS - Diluted	-2.81	-2.79	-0.95	-1.32	-1.2
Diluted EPS - Continuing Operations	-2.81	-2.79	-0.95	-1.32	-1.2
Diluted Weighted Average Shares Outstanding	33.55M	37.79M	78.89M	90.92M	116M
Normalized Basic EPS	-1.78	-1.74	-0.59	-0.82	-0.75
Normalized Diluted EPS	-1.78	-1.74	-0.59	-0.82	-0.75
Supplemental Items
EBITDA	-93.2M	-99.37M	-68.86M	-114M	-132M
EBITA	-97.94M	-106M	-75.21M	-120M	-140M
EBIT	-97.94M	-106M	-75.21M	-120M	-140M
EBITDAR	-86.54M	-91.86M	-60.89M	-105M	-118M
Total Revenues (As Reported)	-	4.04M	48.21M	19.94M	16.34M
Normalized Net Income	-59.86M	-65.9M	-46.42M	-74.8M	-86.56M
Interest on Long-Term Debt	-	-	-	1.24M	4.04M
Supplemental Operating Expense Items
General and Administrative Expenses	19.41M	21.41M	25.93M	28.97M	28.78M
Research And Development Expense From Footnotes	82.9M	88.64M	97.49M	111M	127M
Net Rental Expense, Total	6.65M	7.52M	7.97M	8.8M	13.59M
Imputed Operating Lease Interest Expense	-	-	-	2.6M	6.05M
Imputed Operating Lease Depreciation	-	-	-	6.19M	7.54M
Stock-Based Comp., COGS (Total)	3.44M	4.45M	6.63M	6.73M	6.27M
Stock-Based Comp., G&A Exp. (Total)	1.86M	2.66M	3.93M	5.83M	5.35M
Total Stock-Based Compensation	5.3M	7.11M	10.55M	12.56M	11.62M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	57.41M	170M	93.29M	55.5M	62.99M
Short Term Investments	70.37M	1M	108M	116M	16.29M
Total Cash And Short Term Investments	128M	171M	202M	172M	79.27M
Accounts Receivable, Total	-	-	1.38M	-	-
Other Receivables	482K	-	980K	664K	231K
Total Receivables	482K	-	2.36M	664K	231K
Prepaid Expenses	2.72M	4.06M	4.44M	5.4M	4.84M
Restricted Cash	-	-	11.28M	3.98M	2.3M
Other Current Assets, Total	290K	268K	866K	951K	787K
Total Current Assets	131M	175M	221M	183M	87.44M
Gross Property Plant And Equipment	60.65M	60.37M	66.82M	67.6M	117M
Accumulated Depreciation	-10.31M	-16.92M	-22.28M	-28.78M	-32.42M
Net Property Plant And Equipment	50.34M	43.45M	44.54M	38.82M	84.12M
Long-term Investments	-	-	4.62M	4.03M	-
Other Long-Term Assets, Total	2.78M	2.73M	8.36M	15.03M	6.21M
Total Assets	184M	222M	278M	241M	178M
Liabilities
Accounts Payable, Total	4.62M	9.58M	4.23M	8.69M	3.82M
Accrued Expenses, Total	6.66M	7.96M	11.04M	15.68M	14.27M
Current Portion of Leases	2.5M	5.87M	7.48M	5.29M	6.9M
Unearned Revenue Current, Total	4.96M	3.48M	17.2M	5.13M	2.35M
Other Current Liabilities	761K	96K	-	-	-
Total Current Liabilities	19.5M	26.99M	39.96M	34.8M	27.34M
Long-Term Debt	-	-	-	19.35M	40.14M
Long-Term Leases	20.98M	19.22M	18.94M	15.67M	57.73M
Unearned Revenue Non Current	9.56M	8.22M	3.13M	-	-
Other Non Current Liabilities	-	395K	-	150K	709K
Total Liabilities	50.04M	54.83M	62.02M	69.97M	126M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	17K	18K	20K	22K	22K
Additional Paid In Capital	355M	493M	618M	692M	711M
Retained Earnings	-221M	-326M	-401M	-521M	-660M
Comprehensive Income and Other	24K	-	-73K	-80K	3K
Total Common Equity	134M	167M	216M	171M	51.85M
Total Equity	134M	167M	216M	171M	51.85M
Total Liabilities And Equity	184M	222M	278M	241M	178M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	36.98M	48.95M	72.71M	87.66M	98.07M
ECS Total Common Shares Outstanding	36.33M	47.55M	69.05M	86.89M	97.59M
Book Value / Share	3.7	3.51	3.13	1.97	0.53
Tangible Book Value	134M	167M	216M	171M	51.85M
Tangible Book Value Per Share	3.7	3.51	3.13	1.97	0.53
Total Debt	23.49M	25.1M	26.42M	40.32M	105M
Net Debt	-104M	-146M	-180M	-136M	25.5M
Debt Equivalent Oper. Leases	53.22M	60.14M	63.78M	70.38M	109M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	23.9M	25.24M	27.78M	30.75M	33.95M
Full Time Employees	174	169	193	233	231
Assets under Capital Lease - Gross	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-94.43M	-105M	-75.08M	-120M	-138M
Depreciation & Amortization - CF	4.74M	6.64M	6.35M	6.56M	7.59M
Depreciation & Amortization, Total	4.74M	6.64M	6.35M	6.56M	7.59M
Amortization of Deferred Charges, Total - (CF)	-	-	-	392K	1.41M
(Gain) Loss From Sale Of Asset	-	-	-	-	22K
(Gain) Loss on Sale of Investments - (CF)	-1.35M	-122K	817K	-372K	-2.7M
Asset Writedown & Restructuring Costs	-	-	-	-	1.97M
Stock-Based Compensation (CF)	5.3M	7.11M	10.55M	12.56M	11.62M
Other Operating Activities, Total	6.38M	7.51M	8.05M	9.13M	14.06M
Change In Accounts Payable	45K	826K	-419K	1.88M	-1.97M
Change in Unearned Revenues	-4.3M	-2.82M	8.63M	-15.2M	-2.78M
Change in Other Net Operating Assets	-1.4M	-2.94M	-9.58M	-11.21M	-12.39M
Cash from Operations	-85.01M	-89.1M	-50.68M	-116M	-122M
Capital Expenditure	-16.17M	-3.52M	-5.46M	-5.87M	-4.57M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	32.01M	69.46M	-113M	-7.09M	107M
Other Investing Activities, Total	-	-	-238K	-	-
Cash from Investing	15.84M	65.95M	-119M	-12.96M	102M
Long-Term Debt Issued, Total	-	-	-	19.13M	19.92M
Total Debt Issued	-	-	-	19.13M	19.92M
Long-Term Debt Repaid, Total	-	-	-56K	-228K	-240K
Total Debt Repaid	-	-	-56K	-228K	-240K
Issuance of Common Stock	75.2M	136M	117M	65.51M	8.93M
Repurchase of Common Stock	-	-	-	-890K	-946K
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-807K	-104K	-8.39M	-420K	-2.55M
Cash from Financing	74.4M	136M	109M	83.1M	25.12M
Net Change in Cash	5.22M	113M	-60.47M	-45.81M	5.81M
Supplemental Items
Cash Interest Paid	-	-	-	647K	2.42M
Levered Free Cash Flow	-64.43M	-52.74M	-38.84M	-57.4M	-79.98M
Unlevered Free Cash Flow	-64.43M	-52.74M	-38.84M	-57.02M	-78.87M
Change In Net Working Capital	-2.92M	-3.28M	3.27M	-5M	6.24M
Net Debt Issued / Repaid	-	-	-56K	18.9M	19.68M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-32.74	-32.64	-18.81	-29.01	-41.7
Return on Total Capital	-38.57	-37.9	-21.64	-33.19	-47.46
Return On Equity %	-66.63	-69.96	-39.23	-61.88	-124.41
Return on Common Equity	-66.63	-69.96	-39.23	-61.88	-124.41
Margin Analysis
Gross Profit Margin %	-1.8K	-2.1K	-102.2	-458.55	-678.16
SG&A Margin	444.65	530.37	53.79	145.25	176.11
EBITDA Margin %	-2.14K	-2.46K	-142.83	-570.91	-807.82
EBITA Margin %	-2.24K	-2.63K	-155.99	-603.8	-854.26
EBIT Margin %	-2.24K	-2.63K	-155.99	-603.8	-854.26
Income From Continuing Operations Margin %	-2.16K	-2.61K	-155.73	-600.09	-847.34
Net Income Margin %	-2.16K	-2.61K	-155.73	-600.09	-847.34
Net Avail. For Common Margin %	-2.16K	-2.61K	-155.73	-600.09	-847.34
Normalized Net Income Margin	-1.37K	-1.63K	-96.27	-375.05	-529.59
Levered Free Cash Flow Margin	-1.48K	-1.31K	-80.55	-287.8	-489.35
Unlevered Free Cash Flow Margin	-1.48K	-1.31K	-80.55	-285.9	-482.55
Asset Turnover
Asset Turnover	0.02	0.02	0.19	0.08	0.08
Fixed Assets Turnover	0.11	0.09	1.1	0.48	0.27
Short Term Liquidity
Current Ratio	6.73	6.5	5.52	5.25	3.2
Quick Ratio	6.58	6.34	5.11	4.96	2.91
Operating Cash Flow to Current Liabilities	-4.36	-3.3	-1.27	-3.33	-4.45
Average Days Payable Outstanding	20.8	29.31	25.85	21.17	17.96
Long Term Solvency
Total Debt/Equity	17.48	15.05	12.23	23.61	202.07
Total Debt / Total Capital	14.88	13.08	10.89	19.1	66.9
LT Debt/Equity	15.62	11.53	8.76	20.51	188.76
Long-Term Debt / Total Capital	13.3	10.02	7.81	16.59	62.49
Total Liabilities / Total Assets	27.14	24.75	22.3	29.06	70.83
EBIT / Interest Expense	-	-	-	-97.51	-34.59
EBITDA / Interest Expense	-	-	-	-85.08	-29.35
(EBITDA - Capex) / Interest Expense	-	-	-	-89.83	-30.48
Total Debt / EBITDA	-0.27	-0.27	-0.43	-0.38	-0.88
Net Debt / EBITDA	1.21	1.59	2.95	1.29	-0.22
Total Debt / (EBITDA - Capex)	-0.23	-0.26	-0.4	-0.36	-0.85
Net Debt / (EBITDA - Capex)	1.02	1.53	2.71	1.22	-0.21
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	267.73	-7.51	1.09K	-58.63	-18.05
Gross Profit, 1 Yr. Growth %	46.03	7.74	-41.76	85.6	21.19
EBITDA, 1 Yr. Growth %	51.23	6.63	-30.7	65.36	15.95
EBITA, 1 Yr. Growth %	49.34	8.25	-29.06	60.12	15.94
EBIT, 1 Yr. Growth %	49.34	8.25	-29.06	60.12	15.94
Earnings From Cont. Operations, 1 Yr. Growth %	45.79	11.52	-28.71	59.41	15.71
Net Income, 1 Yr. Growth %	45.79	11.52	-28.71	59.41	15.71
Normalized Net Income, 1 Yr. Growth %	46.62	10.08	-29.56	59.41	15.71
Diluted EPS Before Extra, 1 Yr. Growth %	-61.25	-0.98	-65.84	38.69	-9.09
Net Property, Plant and Equip., 1 Yr. Growth %	70.67	-13.69	2.52	-12.86	116.71
Total Assets, 1 Yr. Growth %	-2.73	20.16	25.52	-13.43	-26.16
Tangible Book Value, 1 Yr. Growth %	-9.91	24.11	29.6	-20.97	-69.64
Common Equity, 1 Yr. Growth %	-9.91	24.11	29.6	-20.97	-69.64
Cash From Operations, 1 Yr. Growth %	122.76	4.81	-43.12	128.79	4.92
Capital Expenditures, 1 Yr. Growth %	185.59	-78.27	55.42	7.49	-22.14
Levered Free Cash Flow, 1 Yr. Growth %	88.15	-18.14	-26.36	47.72	39.33
Unlevered Free Cash Flow, 1 Yr. Growth %	88.15	-18.14	-26.36	46.83	38.31
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	84.42	232.35	122.27	-41.78
Gross Profit, 2 Yr. CAGR %	48.33	25.43	-20.79	3.97	49.98
EBITDA, 2 Yr. CAGR %	53.04	26.99	-14.04	7.04	38.47
EBITA, 2 Yr. CAGR %	53.14	27.14	-12.37	6.58	36.25
EBIT, 2 Yr. CAGR %	53.14	27.14	-12.37	6.58	36.25
Earnings From Cont. Operations, 2 Yr. CAGR %	51.07	27.51	-10.83	6.61	35.81
Net Income, 2 Yr. CAGR %	51.07	27.51	-10.83	6.61	35.81
Normalized Net Income, 2 Yr. CAGR %	51.86	27.04	-11.95	6.61	35.81
Diluted EPS Before Extra, 2 Yr. CAGR %	-63.13	-38.06	-41.85	-31.22	12.28
Net Property, Plant and Equip., 2 Yr. CAGR %	36.01	21.37	-5.93	-5.48	37.42
Total Assets, 2 Yr. CAGR %	25.38	8.11	22.81	4.24	-20.05
Tangible Book Value, 2 Yr. CAGR %	50.07	5.74	26.82	1.2	-51.02
Common Equity, 2 Yr. CAGR %	50.07	5.74	26.82	1.2	-51.02
Cash From Operations, 2 Yr. CAGR %	55.91	52.8	-22.79	14.07	54.93
Capital Expenditures, 2 Yr. CAGR %	18.48	-21.22	-41.88	29.25	-8.52
Levered Free Cash Flow, 2 Yr. CAGR %	44.13	24.1	-22.36	4.32	43.46
Unlevered Free Cash Flow, 2 Yr. CAGR %	44.13	24.1	-22.36	3.98	42.51
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	243.75	65.94	59.38
Gross Profit, 3 Yr. CAGR %	78.04	33.34	-2.87	5.21	9.42
EBITDA, 3 Yr. CAGR %	72.5	35.67	3.77	6.91	9.93
EBITA, 3 Yr. CAGR %	72.8	36.41	4.67	7.13	9.61
EBIT, 3 Yr. CAGR %	72.8	36.41	4.67	7.13	9.61
Earnings From Cont. Operations, 3 Yr. CAGR %	71.41	36.53	5.05	8.22	9.56
Net Income, 3 Yr. CAGR %	71.41	36.53	5.05	8.22	9.56
Normalized Net Income, 3 Yr. CAGR %	72.36	36.41	4.37	7.71	9.56
Diluted EPS Before Extra, 3 Yr. CAGR %	-36.92	-48.75	-49.21	-22.3	-24.52
Net Property, Plant and Equip., 3 Yr. CAGR %	88.71	16.88	14.73	-8.3	24.63
Total Assets, 3 Yr. CAGR %	58.37	23.61	13.63	9.3	-7.08
Tangible Book Value, 3 Yr. CAGR %	90.44	40.86	13.16	8.33	-32.25
Common Equity, 3 Yr. CAGR %	90.44	40.86	13.16	8.33	-32.25
Cash From Operations, 3 Yr. CAGR %	77.15	36.58	9.92	10.9	10.94
Capital Expenditures, 3 Yr. CAGR %	32.3	-32.68	-1.19	-28.66	9.16
Levered Free Cash Flow, 3 Yr. CAGR %	-	19.36	4.29	-3.77	14.89
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	19.36	4.29	-3.99	14.36
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	68.96
Gross Profit, 5 Yr. CAGR %	-	-	28.77	20.71	15.56
EBITDA, 5 Yr. CAGR %	-	-	30.55	23.4	16.46
EBITA, 5 Yr. CAGR %	-	-	31.7	23.59	16.31
EBIT, 5 Yr. CAGR %	-	-	31.7	23.59	16.31
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	31.98	23.67	16.41
Net Income, 5 Yr. CAGR %	-	-	31.98	23.67	16.41
Normalized Net Income, 5 Yr. CAGR %	-	-	31.75	23.57	16.22
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-38.94	-42.33	-30.24
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	42.84	7.36	23.32
Total Assets, 5 Yr. CAGR %	-	-	43.05	15.47	-1.28
Tangible Book Value, 5 Yr. CAGR %	-	-	61.86	23.41	-19.05
Common Equity, 5 Yr. CAGR %	-	-	61.86	23.41	-19.05
Cash From Operations, 5 Yr. CAGR %	-	-	27.08	27.09	26.09
Capital Expenditures, 5 Yr. CAGR %	-	-	-4.79	-12.61	-4.19
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	13.1	18.49
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	12.95	18.16